genesis

Solvay Joins Genesis Consortium to Boost Biotech

Solvay’s venture capital fund has joined the Genesis Consortium, a global alliance of venture capital firms and corporations that support startups leveraging biotechnology to promote both human and planetary health.

News

Tronox Agrees Sale of Alkali Assets

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Industry Kick-Off with Signal Effect: More Than 310 Exhibitors expected at maintenance and PUMPS & VALVES 2026

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

WuXi AppTec

Europe’s Biotech Inflection Point

Together for Sustanability (TFS)

Driving Sustainability Through Collaboration

Dow Chemical Company

Anchored in Sustainability

Easyfairs Deutschland GmbH

Leading the way. Driving results.

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Solvay